In conjunction with
Sign up for the newsletter
Session summary 2010 in chronological order
Monday, 25 October 2010
 | 10.00-12.00 Nutraceutics: regulatory, academic and industrial aspects | ||
| 12.00-13.00 Feed-Food (of animal origin) and health | ||
| 14.30-16.15 Food and Health | ||
Tuesday, 26 October 2010
 | 10.30-11.30 Welcome and Opening Plenary Session | ||
| 11.30-13.00 Roundtable: The role of Charities and Bank Foundations in boosting public and private investment in R&D | ||
| 14.00-16.00 State of the art of the biosimilars market | ||
| 14.00-16.30 Potentialities of microbial enzymes in the production of nutraceutical ingredients, and functional foods & drinks | ||
| 14.00-18.00 Nanotechnologies and Cosmetics | ||
| 14.05-15.30 Food supplements: regulatory issues and market | ||
| 15.30-18.10 Nutraceuticals: new tools for therapy and novel areas of business development | ||
Wednesday, 27 October 2010
 | 10.00-11.15 Microalgae and macroalgae in cosmetics | ||
| 10.00-11.00 The role of tech transfer and intellectual property in biotech | ||
| 10.00-13.00 Innovation in dietary supplement ingredients for health and beauty | ||
| 10.00-11.20 Roundtable: Advanced Therapies: where are the opportunities? | ||
| 11.00-13.00 Biotech Start up Challenge | ||
| 11.20-13.00 Microalgae e macroalgae as food | ||
| 11.30-13.00 Nanotechnologies for the biotech industry | ||
| 14.00-15.00 Microalgae and Macroalgae with medical activities | ||
| 14.00-15.20 Neurodegeneration: progresses and challenges | ||
| 14.00-17.00 Ingredients for skin and hair benefits | ||
| 14.00-15.30 The evolution of oncology drug development | ||
| 15.10-17.00 Microalgae and macroalgae as bioenergy and biosensors | ||
| 15.30-17.20 International collaborations in the biotech sector: overview on the European projects in the region. What benefits for industry and research? | ||
| 15.30-17.30 Bioengineering, an emerging avenue in regenerative medicine | ||
Thursday, 28 October 2010
| 10.00-12.50 Biotechnology and the new challenges of the nutritional research | ||
| 10.00-11.30 Where is white biotechnology going? | ||
| 11.30-13.00 The future of orphan drugs | ||
| 12.00-13.00 Opinion of the European Federations of food and food ingredients industries | ||
| 14.00-15.30 Opinions of food and food ingredients producing Companies | ||
| 15.30-17.30 Roundtable | ||